# VRC 313: A Trivalent Virus-like Particle (VLP) Encephalitis Vaccine (WEVEE) in Healthy Adults

> **NCT03879603** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 30 (actual)

## Conditions studied

- Venezuelan Equine Encephalitis
- Western Equine Encephalitis
- Eastern Equine Encephalitis
- Alphavirus Infections

## Interventions

- **BIOLOGICAL:** VRC-WEVVLP073-00-VP
- **OTHER:** VRC-GENMIX083-AL-VP

## Key facts

- **NCT ID:** NCT03879603
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-02
- **Primary completion:** 2020-02-26
- **Final completion:** 2020-02-26
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03879603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03879603, "VRC 313: A Trivalent Virus-like Particle (VLP) Encephalitis Vaccine (WEVEE) in Healthy Adults". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03879603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*